The Cost of Mental Health Care: A Cost-Sharing Law

By Staff Writer

March 31, 2024

Introduction:

The scarcity of mental health and substance use disorder (MH/SUD) treatment is a significant public health issue in the US, contributing to high levels of morbidity and mortality. Many people with MH/SUDs often hesitate to seek health care due to stigma and the lack of accessible clinicians. For those with commercial insurance, out-of-pocket expenses due to cost-sharing serve as another barrier. This article examines the mental health landscape in the US and the impact of cost-sharing laws on the cost of healthcare, focusing on the New Mexico No Behavioural Health Cost Sharing (NCS) law.

Who Receives Mental Health Care?

Persistent disparities exist in access to mental health care. In 2021, only 47% of US adults with mental illness received any mental health services. Workforce shortages contribute to this issue, with more than half of US residents living in areas short of mental health professionals. Even insured individuals often find it difficult to use their insurance for care, as nearly half of psychiatrists do not accept insurance. In 2021, 55% of people with serious mental illness who needed but did not receive mental health care cited unaffordability as the main barrier. Inadequate insurance payment and coverage was the primary obstacle for an additional 33%.

Towards More Equitable Access

The tradition of private practice psychiatry, coupled with the availability of cash-paying patients, exacerbates mental health workforce shortages, especially when demand outstrips supply. Despite expansions in insurance coverage and legal mandates that health plans include mental health care coverage, out-of-pocket costs remain a significant barrier. In 2021, racial and ethnic disparities in treatment rates were also evident.

The Implications of Cost-Sharing

Cost-sharing, which includes copayments, coinsurance, and deductibles, is designed to curb the overuse of health care. However, for individuals with MH/SUDs, cost-sharing can discourage the use of effective treatments. The RAND Health Insurance experiment in the 1970s demonstrated this, showing that higher cost-sharing led to larger reductions in mental health care than other health care use.

The New Mexico No Behavioural Health Cost Sharing Law

In April 2021, New Mexico passed the NCS law, prohibiting cost-sharing for MH/SUD treatment for individuals with commercial insurance plans. This law was a response to the need to reduce the costs of MH/SUD treatment, given the vast personal and societal costs of these conditions. However, the impact of the law on patient outcomes is yet to be fully understood.

The Impact of the New Mexico No Behavioural Health Cost Sharing Law

In order to lower MH/SUD treatment costs, the NCS was passed. The NCS applies solely to state-regulated commercial insurance plans, including fully insured, employer-sponsored plans, individual market plans, and New Mexico state employee health plans (SEHPs), which cover public school employees. The data suggests that the NCS effectively shielded patients from out-of-pocket spending on medications for MH/SUDs. A recent study discovered that the average out-of-pocket expense for psychotropic medications decreased by $6.37, or 85.6%, when compared to New Mexico federal employees who were not impacted by NCS. However, the overall volume of dispensed MH/SUD prescription drugs did not significantly change.

Conclusion:

New Mexico’s NCS law provides a case study on how legislation can tackle financial obstacles to mental health care. It has effectively cut down out-of-pocket costs for psychotropic drugs. However, the total amount of dispensed MH/SUD prescription drugs hasn’t changed significantly. This situation highlights the complex nature of mental health care access. It’s not just about cost, but also about professional availability and lingering mental health stigma. We have yet to see the law’s effect on non-drug services. Yet, the initial success in lessening the financial strain of medication signals a hopeful beginning. Despite this, the data on mental health care access indicates a long road to equitable mental health care. It’s clear that while laws like NCS can contribute, we need a multi-faceted strategy. This strategy should address workforce shortages, insurance coverage, and societal stigma.

Reference url

Recent Posts

prior authorization reforms
     

Streamlining Prior Authorization Reforms: Impacts and Insights for HEOR

🚀 Are prior authorizations stalling care delivery in the U.S. healthcare system?

The HHS has launched an ambitious collaboration with major insurers to reform prior authorization processes across Medicare Advantage, Medicaid, and commercial plans. With a goal to standardize submissions by 2027 and significantly reduce requirements by 2026, this initiative promises to accelerate care decisions and enhance transparency.

Dive into the details of these pivotal reforms and discover their potential to streamline healthcare and improve patient outcomes.

#SyenzaNews #HealthcareInnovation #healthcare #healthcarepolicy

private health funding
    

Private Health Funding Under South Africa’s National Health Insurance Act

🚀 Update on NHI in South Africa.

In their insightful article, Solanki et al. discuss the complexities of private health funding amidst the nation’s National Health Insurance Act. They discuss two key scenarios: a passive approach that risks the sustainability of the private sector and an active reform strategy that could ensure a smoother transition to universal coverage.

Curious about how these strategies could reshape healthcare access and costs in South Africa? Don’t miss out on this critical analysis!

#SyenzaNews #HealthEconomics #HealthcarePolicy

drug price transparency
     

Impending Net Drug Price Transparency Regulation in the U.S.

💡 Are you ready for a potential game-changer in drug pricing transparency?

CMS Administrator Mehmet Oz has hinted at a new rule aimed at enforcing stricter disclosures for drug prices, requiring healthcare companies to reveal actual transaction costs. This could reshape how price transparency is managed across the industry and challenge pharmacy benefit managers to rethink rebate practices.

Curious about how this will impact healthcare economics and what it means for drug affordability? Dive into the article for all the insights!

#SyenzaNews #healthcare #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.